https://www.selleckchem.com/pr....oducts/NVP-ADW742.ht
IC developed in 27 patients (11.5%), and day 28 mortality was 29.1%. Finally, BDG 80 pg/mL at inclusion was associated with an increased risk of IC (CSHR[IC], 4.67; 95% CI, 1.61-13.5) but not death (CSHR[death], 1.20; 95% CI, 0.71-2.02). Among high-risk patients, a first measurement of BDG 80 pg/mL was strongly associated with the occurrence of IC. Neither a cutoff of 250 pg/mL nor repeated measurements of fungal biomarkers seemed to be useful to predict the occurrence of IC. The cumulative risk of IC in the placebo group if
Like
Comment
Share
